8-K: FIGS Inc. Reports Mixed Q1 2024 Results, Raises Full-Year Revenue Outlook

FIGS Inc. announced its Q1 2024 financial results, with net revenues at the upper end of expectations and adjusted EBITDA margin exceeding guidance, leading to an increased full-year revenue outlook.

Summary

• FIGS Inc. released its first quarter 2024 financial results, showing net revenues of $119.3 million, a slight decrease of 0.8% year-over-year.
• The company's gross margin was 68.9%, down 2.4% year-over-year, primarily due to a shift in product mix.
• Operating expenses decreased slightly by 0.8% year-over-year to $81.7 million.
• Net income was $1.4 million, or $0.01 per diluted share, a decrease compared to the same period last year.
• Adjusted EBITDA was $13.0 million, a decrease of $3.1 million year-over-year, with an adjusted EBITDA margin of 10.9%.
• Active customers increased by 8.7% year-over-year to 2.6 million, while net revenue per active customer decreased by 2.8% to $210.
• The average order value (AOV) increased by 1.8% year-over-year to $116.
• FIGS has raised its full-year 2024 net revenue outlook to -2% to +2% growth compared to 2023, while adjusting its EBITDA margin outlook to 9.5% 10.5%.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the company exceeded expectations for adjusted EBITDA margin and saw growth in active customers, there were declines in net revenue, gross margin, and net income. The raised full-year revenue outlook is a positive sign, but the mixed results and increased investments in marketing suggest a need for caution.

Positives

• Net revenues reached the upper end of the company's expectations.
• Adjusted EBITDA margin exceeded the company's guidance.
• There was improved momentum in repeat customer frequency.
• Active customers increased by 8.7% year-over-year.
• Average order value increased by 1.8% year-over-year.
• The company is strategically increasing investments in marketing.
• The full-year net revenue outlook has been raised.
• The company expects to sustain strong free cash flow.

Negatives

• Net revenues decreased slightly by 0.8% year-over-year.
• Gross margin decreased by 2.4% year-over-year.
• Net income decreased by $0.5 million year-over-year.
• Adjusted EBITDA decreased by $3.1 million year-over-year.
• Net revenue per active customer decreased by 2.8% year-over-year.
• Adjusted EBITDA margin decreased from 13.4% to 10.9% year-over-year.

Risks

• The company's ability to maintain its historical growth is a risk.
• Maintaining profitability is a key challenge.
• The company faces risks related to maintaining brand value and reputation.
• Attracting and retaining customers is crucial for future success.
• The company's marketing efforts must be successful.
• The company needs to maintain a strong community of engaged customers and ambassadors.
• Negative publicity related to marketing or social media use could impact the company.
• The company must successfully develop and introduce new products.
• The market for healthcare apparel is competitive.
• The company relies on a limited number of third-party suppliers.
• Fluctuating costs of raw materials could impact profitability.
• The company must protect its intellectual property rights and customer data.
• Macroeconomic trends could impact the company's operations.

Future Outlook

FIGS has raised its full-year 2024 net revenue outlook to -2% to +2% growth compared to 2023 and adjusted its EBITDA margin outlook to 9.5% 10.5%. The company expects to sustain strong free cash flow.

Management Comments

• Trina Spear, Chief Executive Officer and Co-Founder, stated that net revenues came in at the upper end of expectations with adjusted EBITDA margin exceeding guidance.
• Trina Spear noted improved momentum in the business, particularly in repeat frequency trends.
• Trina Spear mentioned that recent performance reflects strong engagement with new product innovation and storytelling campaigns.
• Management is strategically ramping investments, predominantly in marketing, to further fuel growth.

Industry Context

The healthcare apparel market is competitive, and FIGS is working to maintain its position through product innovation and marketing. The company's focus on direct-to-consumer sales and brand building is consistent with trends in the broader retail industry.

Comparison to Industry Standards

• FIGS's gross margin of 68.9% is relatively high compared to traditional apparel retailers, but it is down year-over-year, indicating potential pricing or cost pressures.
• The company's adjusted EBITDA margin of 10.9% is a key metric for profitability, and while it exceeded guidance, it is lower than the previous year, suggesting increased operating costs or competitive pressures.
• Companies like Lululemon and Nike, which also focus on premium activewear, often have higher gross margins, but FIGS operates in a niche market with a specific customer base.
• FIGS's growth in active customers is a positive sign, but the decrease in net revenue per active customer suggests a need to improve customer engagement and spending.

Stakeholder Impact

• Shareholders may react positively to the raised revenue outlook but negatively to the decreased profitability metrics.
• Employees may see increased opportunities due to the company's growth and investments.
• Customers may benefit from new product innovations and marketing campaigns.
• Suppliers may see increased demand due to the company's growth.

Next Steps

• FIGS management will host a conference call and webcast to discuss the financial and business results.
• The company will continue to strategically invest in marketing to fuel growth.
• The company will focus on sustaining strong free cash flow to support long-term profitable growth.

Key Dates

Keywords

FIGS, healthcare apparel, financial results, net revenue, EBITDA, gross margin, active customers, average order value, marketing, retail